We amplified sequences of the Chlamydia pneumoniae (C P) major-outer membrane protein in the cerebrospinal fluid (CSF) from 23 of 107 (21.5%) relapsing-remitting or secondary progressive multiple sclerosis (MS) patients and two of 77 (2.6%) patients with other neurological diseases (OND) (P =0.00022). C P+ patients showed magnetic resonance imaging (MRI) evidence of more active disease (P =0.02) compared to CP-MS patients and tended to have an anticipation of age at disease onset (32.39-12 versus 28.59-10 years; P =ns) causing a longer disease duration (7.59-5 versus 4.49-4 years; P =0.016) at the time of clinical evaluation. These findings, although indirectly, suggest that C P infection of the central nervous system (C NS) might affect disease course in a subgroup of MS patients.
Willer CJ , Ebers GC.Susceptibility to multiple sclerosis: interplay between genes and environment . Curr Opin Neurol2000; 13: 241-247 .
2.
Gilden D.Chlamydia: a role for multiple sclerosis or more confusion ? Ann Neurol1999; 46: 4-5 .
3.
Sriram Set al.Chlamydia pneumoniae infection of the central nervous system and multiple sclerosis . Ann Neurol1999; 46: 6-14 .
4.
Boman Jet al.Failure to detect Chlamydia pneumoniae in central nervous system of patients with MS . Neurology2000; 54: 265-265 .
5.
Dong-Si Tet al.Chlamydia pneumoniae is frequently found in cerebrospinal fluid of patients with multiple sclerosis . Proceedings of the 125th Annual Meeting of the American Neurological Association Boston, USA, 2000. Abstract 117.
6.
Ke Zet al.Lack of detectable Chlamydia pneumoniae in brain lesions of patients with multiple sclerosis . Ann Neurol2000; 48: 400-400 .
7.
Layh-Schmitt Get al.Evidence for infection with Chlamydia pneumoniae in a subgroup of patients with multiple sclerosis . Ann Neurol2000; 47: 652-655 .
8.
Kaufman Met al.Is Chiamydia pneumoniae found in spinal fluid samples from multiple sclerosis patients? Conflicting results . Mult Scler2002; 8: 289-294 .
9.
Treib Jet al.Multiple sclerosis and Chlamydia pneumoniae . Ann Neurol2000; 47: 408-408 .
10.
Sotgiu Set al.Chlamydia pneumoniae in the cerebrospinal fluid of patients with multiple sclerosis and neurological controls . Mult Scler2001; 7: 371-374 .
Ormerod IEet al.The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study . Brain1987; 110: 1579-1616 .
13.
Andersson Met al.Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report . J Neurol Neurosur Psychiatry1994; 57: 897-902 .
14.
Boman Jet al.High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors . J Infect Dis1998; 178: 274-277 .
15.
Tong CYW , Sillis M.Detection of Chlamydia pneumoniae and Chlamydia psittaci in sputum samples by PCR . J Clin Pathol1993; 46: 313-317 .
16.
Kwok S.Procedures to minimize PCR-product carry-over. In Innis MA , Gelfand DH , Sninsky JJ , White TJ eds. PCR protocols a guide to methods and applications. San Diego, USA: Academic Press Inc. , 1990: 140-145.
Saikku Pet al.Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study . Ann Intern Med1992; 116: 273-278 .
19.
Kuo CCet al.Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries . J Infect Dis1993; 167: 841-849 .
20.
Cook PJet al.Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia: the West Birmingham Stroke . Stroke1998; 29: 404-410 .
21.
Ieven M , Goossens H.Relevance of nucleic acid amplification techniques for diagnosis of respiratory tract infections in the clinical laboratory . Clin Microbiol Rev1997; 10: 242-256 .
22.
Campbell Let al.Detection of Chlamydia pneumoniae by polymerase chain reaction . J Clin Microbiol1992; 30: 434-439 .
23.
Ikejima Het al.PCR-based method for isolation and detection of Chlamydia pneumoniae DNA in cerebrospinal fluids . Clin Diagn Lab Immunol2001; 8: 499-502 .
24.
Derfuss Tet al.Intrathecal antibody production against Chlamydia pneumoniae in multiple sclerosis is part of a polyspecific immune response . Brain2001; 124: 1325-1335 .
25.
Black CM , Fields P , Messmer T , Berdal B.Detection of Chlamydia pneumoniae in clinical specimens by polymerase chain reaction using nested primers . Eur J Clin Microbiol Infect Dis1994; 13: 752-756 .
26.
Boman Jet al.Rapid diagnosis of respiratory Chlamydia pneumoniae infection by nested touchdown polymerase chain reaction compared with culture and antigen detection by EIA . J Infect Dis1997; 175: 1523-1526 .
27.
Hao Qet al.Chlamydia pneumoniae infection associated with enhanced MRI spinal lesions in multiple sclerosis . Mult Scler2002; 8: 436-440 .
28.
Kira Jet al.Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders . Ann Neurol1996; 40: 569-574 .
29.
Krametter Det al.Chlamydia pneumoniae in multiple sclerosis: humoral immune responses in serum and cerebrospinal fluid and correlation with disease activity marker . Mult Scler2001; 7: 13-18 .
30.
Blasi Fet al.Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms . J Clin Microbiol1996; 34: 2677-2769 .
31.
Juvonen Jet al.Demonstration of Chlamydia pneumoniae in the walls of abdominal aortic aneurysms . J Vasc Surg1997; 25: 499-505 .
32.
Hunter SF , Hafler DA.Ubiquitous pathogens: links between infection and autoimmunity in MS ? Neurology2000; 55: 164-165 .
33.
Wandinger Ket al.Association between clinical disease activity and Epstein-Barr virus reactivation in MS . Neurology2000; 55: 178-184 .
34.
Paty DW , Li DK.Interferon beta-1b is effective in relapsingremitting multiple sclerosis. MRI analysis results of a multi-center, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group . Neurology1993; 43: 662-667 .
